Dintsios, C. M., & Beinhauer, I. (2020). The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany. BMC.
Chicago-tyylinen lähdeviittausDintsios, C. M., ja I. Beinhauer. The Impact of Additive or Substitutive Clinical Study Design On the Negotiated Reimbursement for Oncology Pharmaceuticals After Early Benefit Assessment in Germany. BMC, 2020.
MLA-viiteDintsios, C. M., ja I. Beinhauer. The Impact of Additive or Substitutive Clinical Study Design On the Negotiated Reimbursement for Oncology Pharmaceuticals After Early Benefit Assessment in Germany. BMC, 2020.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.